You are here: Home » News-CM » Companies » Results
Business Standard

Aurobindo Pharma standalone net profit declines 21.41% in the June 2017 quarter

Capital Market 

Sales decline 9.99% to Rs 2131.78 crore

Net profit of Pharma declined 21.41% to Rs 307.33 crore in the quarter ended June 2017 as against Rs 391.03 crore during the previous quarter ended June 2016. Sales declined 9.99% to Rs 2131.78 crore in the quarter ended June 2017 as against Rs 2368.41 crore during the previous quarter ended June 2016. ParticularsQuarter EndedJun. 2017Jun. 2016% Var.Sales2131.782368.41 -10 OPM %22.0423.92 -PBDT490.01573.42 -15 PBT406.62503.02 -19 NP307.33391.03 -21

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU